Cell line characterization is key to ensuring the safety of biologics. Even with recent innovations in adventitious agent detection for cell banks, transmission electron microscopy (TEM) remains a ...

There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...

Synthekine Inc., an engineered cytokine therapeutics company, today announced that the company has dosed the first patient in the SYNERGY-101 study. SYNERGY-101 is a global, randomized Phase 2 ...

Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. | Third ...

Get the latest insights on Genelux Corp's oncolytic virus pipeline, phase 3 trial update, and financial outlook.

In a nondescript building, one of the largest telecommunications companies houses a data center that powers the Las Vegas ...

The Trump administration has a range of options to confront terrorist groups in northern Nigeria, although the wisdom of such ...

With the musical genre, we often tend to associate joy, love, and all the warm, fuzzy emotions that come with a world ...

One of the oldest challenges in oncology is creating a drug that kills cancer cells while sparing healthy ones. Peptides are ...

The Equal Employment Opportunity Commission (EEOC) has been unusually active in recent months, issuing significant opinions ...

A naturally occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of ...

The autologous CAR-T cell therapy MB-105 has received regenerative medicine advanced therapy (RMAT) designation from the FDA ...